Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets

Marco F. Lombardo, Fabiana De Angelis, Luca Bova, Barbara Bartolini, Federico Bertuzzi, Rita Nano, Barbara Capuani, Renato Lauro, Massimo Federici, Davide Lauro, Giulia Donadel

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The search for factors either promoting islets proliferation or survival during adult life is a major issue for both type 1 and 2 diabetes mellitus. Among factors with mitogenic activity on pancreatic β-cells, human placental lactogen (hPL) showed stronger activity when compared to the other lactogen hormones: growth hormone (GH) and prolactin (PRL). The aim of the present work is to elucidate the biological and molecular events of hPL isoform A (hPL-A) activity on human cultured islets. We used pure human pancreatic islets and insulinoma cell lines (βTC-1 and RIN, murine and rat respectively) stimulated with hPL-A recombinant protein and we compared hPL-A activity with that of hGH. We showed that hPL-A inhibits apoptosis, both in insulinoma and human islets, by the phosphorylation of AKT protein. Indeed, the antiapoptotic role of hPL-A was mediated by PI3K, p38 and it was independent by PKA, Erk1/2. Compared with hGH, hPL-A modulated at different intervals and/or intensity by the phosphorylation of JAKs/STATs and MAPKinases. Moreover, hPL-A induced PDX-1 intracellular expression, improving beta cell activity and ameliorating insulin secretion in response to high glucose stimulation. Our data support the idea that hPL-A is involved in the regulation of beta cells activity. Importantly, we found that hPL-A can preserve and improve the ability of purified human pancreatic islets cultured to secrete insulin in vitro.

Original languageEnglish
Pages (from-to)250-258
Number of pages9
JournalIslets
Volume3
Issue number5
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Placental Lactogen
Islets of Langerhans
Cell Survival
Insulin
Insulinoma
Phosphorylation
Type 1 Diabetes Mellitus
Phosphatidylinositol 3-Kinases
Recombinant Proteins
Human Activities
Prolactin
Type 2 Diabetes Mellitus
Growth Hormone
Protein Isoforms
Hormones
Apoptosis

Keywords

  • β-cell
  • Apoptosis
  • Growth hormone
  • Islets insulin secretion
  • Islets survival
  • PDX-1
  • Placental lactogen hormone

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets. / Lombardo, Marco F.; De Angelis, Fabiana; Bova, Luca; Bartolini, Barbara; Bertuzzi, Federico; Nano, Rita; Capuani, Barbara; Lauro, Renato; Federici, Massimo; Lauro, Davide; Donadel, Giulia.

In: Islets, Vol. 3, No. 5, 09.2011, p. 250-258.

Research output: Contribution to journalArticle

Lombardo, MF, De Angelis, F, Bova, L, Bartolini, B, Bertuzzi, F, Nano, R, Capuani, B, Lauro, R, Federici, M, Lauro, D & Donadel, G 2011, 'Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets', Islets, vol. 3, no. 5, pp. 250-258. https://doi.org/10.4161/isl.3.5.16900
Lombardo, Marco F. ; De Angelis, Fabiana ; Bova, Luca ; Bartolini, Barbara ; Bertuzzi, Federico ; Nano, Rita ; Capuani, Barbara ; Lauro, Renato ; Federici, Massimo ; Lauro, Davide ; Donadel, Giulia. / Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets. In: Islets. 2011 ; Vol. 3, No. 5. pp. 250-258.
@article{68ea7db8cf89446a89ceb8bcba24e74b,
title = "Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets",
abstract = "The search for factors either promoting islets proliferation or survival during adult life is a major issue for both type 1 and 2 diabetes mellitus. Among factors with mitogenic activity on pancreatic β-cells, human placental lactogen (hPL) showed stronger activity when compared to the other lactogen hormones: growth hormone (GH) and prolactin (PRL). The aim of the present work is to elucidate the biological and molecular events of hPL isoform A (hPL-A) activity on human cultured islets. We used pure human pancreatic islets and insulinoma cell lines (βTC-1 and RIN, murine and rat respectively) stimulated with hPL-A recombinant protein and we compared hPL-A activity with that of hGH. We showed that hPL-A inhibits apoptosis, both in insulinoma and human islets, by the phosphorylation of AKT protein. Indeed, the antiapoptotic role of hPL-A was mediated by PI3K, p38 and it was independent by PKA, Erk1/2. Compared with hGH, hPL-A modulated at different intervals and/or intensity by the phosphorylation of JAKs/STATs and MAPKinases. Moreover, hPL-A induced PDX-1 intracellular expression, improving beta cell activity and ameliorating insulin secretion in response to high glucose stimulation. Our data support the idea that hPL-A is involved in the regulation of beta cells activity. Importantly, we found that hPL-A can preserve and improve the ability of purified human pancreatic islets cultured to secrete insulin in vitro.",
keywords = "β-cell, Apoptosis, Growth hormone, Islets insulin secretion, Islets survival, PDX-1, Placental lactogen hormone",
author = "Lombardo, {Marco F.} and {De Angelis}, Fabiana and Luca Bova and Barbara Bartolini and Federico Bertuzzi and Rita Nano and Barbara Capuani and Renato Lauro and Massimo Federici and Davide Lauro and Giulia Donadel",
year = "2011",
month = "9",
doi = "10.4161/isl.3.5.16900",
language = "English",
volume = "3",
pages = "250--258",
journal = "Islets",
issn = "1938-2014",
publisher = "Landes Bioscience",
number = "5",

}

TY - JOUR

T1 - Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets

AU - Lombardo, Marco F.

AU - De Angelis, Fabiana

AU - Bova, Luca

AU - Bartolini, Barbara

AU - Bertuzzi, Federico

AU - Nano, Rita

AU - Capuani, Barbara

AU - Lauro, Renato

AU - Federici, Massimo

AU - Lauro, Davide

AU - Donadel, Giulia

PY - 2011/9

Y1 - 2011/9

N2 - The search for factors either promoting islets proliferation or survival during adult life is a major issue for both type 1 and 2 diabetes mellitus. Among factors with mitogenic activity on pancreatic β-cells, human placental lactogen (hPL) showed stronger activity when compared to the other lactogen hormones: growth hormone (GH) and prolactin (PRL). The aim of the present work is to elucidate the biological and molecular events of hPL isoform A (hPL-A) activity on human cultured islets. We used pure human pancreatic islets and insulinoma cell lines (βTC-1 and RIN, murine and rat respectively) stimulated with hPL-A recombinant protein and we compared hPL-A activity with that of hGH. We showed that hPL-A inhibits apoptosis, both in insulinoma and human islets, by the phosphorylation of AKT protein. Indeed, the antiapoptotic role of hPL-A was mediated by PI3K, p38 and it was independent by PKA, Erk1/2. Compared with hGH, hPL-A modulated at different intervals and/or intensity by the phosphorylation of JAKs/STATs and MAPKinases. Moreover, hPL-A induced PDX-1 intracellular expression, improving beta cell activity and ameliorating insulin secretion in response to high glucose stimulation. Our data support the idea that hPL-A is involved in the regulation of beta cells activity. Importantly, we found that hPL-A can preserve and improve the ability of purified human pancreatic islets cultured to secrete insulin in vitro.

AB - The search for factors either promoting islets proliferation or survival during adult life is a major issue for both type 1 and 2 diabetes mellitus. Among factors with mitogenic activity on pancreatic β-cells, human placental lactogen (hPL) showed stronger activity when compared to the other lactogen hormones: growth hormone (GH) and prolactin (PRL). The aim of the present work is to elucidate the biological and molecular events of hPL isoform A (hPL-A) activity on human cultured islets. We used pure human pancreatic islets and insulinoma cell lines (βTC-1 and RIN, murine and rat respectively) stimulated with hPL-A recombinant protein and we compared hPL-A activity with that of hGH. We showed that hPL-A inhibits apoptosis, both in insulinoma and human islets, by the phosphorylation of AKT protein. Indeed, the antiapoptotic role of hPL-A was mediated by PI3K, p38 and it was independent by PKA, Erk1/2. Compared with hGH, hPL-A modulated at different intervals and/or intensity by the phosphorylation of JAKs/STATs and MAPKinases. Moreover, hPL-A induced PDX-1 intracellular expression, improving beta cell activity and ameliorating insulin secretion in response to high glucose stimulation. Our data support the idea that hPL-A is involved in the regulation of beta cells activity. Importantly, we found that hPL-A can preserve and improve the ability of purified human pancreatic islets cultured to secrete insulin in vitro.

KW - β-cell

KW - Apoptosis

KW - Growth hormone

KW - Islets insulin secretion

KW - Islets survival

KW - PDX-1

KW - Placental lactogen hormone

UR - http://www.scopus.com/inward/record.url?scp=80052773860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052773860&partnerID=8YFLogxK

U2 - 10.4161/isl.3.5.16900

DO - 10.4161/isl.3.5.16900

M3 - Article

C2 - 21765243

AN - SCOPUS:80052773860

VL - 3

SP - 250

EP - 258

JO - Islets

JF - Islets

SN - 1938-2014

IS - 5

ER -